JESSICA HARTLE: Open Payments
NPI 1760015572 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 13 payments from 8 companies in 2025. Trend: 2023 $1,041 · 2024 $1,096 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 3 | $102 |
| AstraZeneca Pharmaceuticals LP | 1 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: SYNERGY ABLATION SYSTEM, FARXIGA, JARDIANCE, LEQVIO, LifeVest, Kerendia, ELIQUIS, VERQUVO.
Industry payments across MI — which companies pay providers there.
